Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.17 HKD
Change Today +0.01 / 0.46%
Volume 2.2M
512 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

china grand pharmaceutical a (512) Snapshot

Open
$2.16
Previous Close
$2.16
Day High
$2.21
Day Low
$2.16
52 Week High
04/21/15 - $2.50
52 Week Low
02/17/15 - $1.27
Market Cap
4.3B
Average Volume 10 Days
1.2M
EPS TTM
$0.09
Shares Outstanding
2.0B
EX-Date
05/20/97
P/E TM
24.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA GRAND PHARMACEUTICAL A (512)

Related News

No related news articles were found.

china grand pharmaceutical a (512) Related Businessweek News

No Related Businessweek News Found

china grand pharmaceutical a (512) Details

China Grand Pharmaceutical and Healthcare Holdings Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations, pharmaceutical intermediates, specialized pharmaceutical raw materials, and healthcare products. The company offers pharmaceutical preparations, such as cerebro-cardiovascular, ophthalmic gel and eye drops, antibacterial, antibiotics, and antipyretics and analgesic products; and active pharmaceutical ingredients (APIs), which include analgin, metronidazole and chloramphenicol, and other amino acids. It also provides steroid hormones APIs and its intermediates, including glucocorticoid and sex hormones, as well as prednisone series. In addition, the company offers Taurine, an organic amino acid that is used to enhance immunity system and increase level of cell differentiation, growth, and supplement in infant milk powder, as well as used in energy drinks and in treatment of various heart diseases. Further, it provides agricultural chemicals comprising bio-pesticides, biocides, and bio-feed additives; and fine chemicals, such as calcium superphosphate and dimethyl sulfate. China Grand Pharmaceutical and Healthcare Holdings Limited operates primarily in the People’s Republic of China, as well as in the United States, Europe, Asia, and internationally. The company was incorporated in 1995 and is based in Central, Hong Kong. China Grand Pharmaceutical and Healthcare Holdings Limited is a subsidiary of Outwit Investments Limited.

5,400 Employees
Last Reported Date: 04/28/15
Founded in 1995

china grand pharmaceutical a (512) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: $1.5M
Compensation as of Fiscal Year 2014.

china grand pharmaceutical a (512) Key Developments

China Grand Pharmaceutical and Healthcare Holdings Ltd. Reports Audited Consolidated Cash Flow Results for the Year Ended December 31, 2014

China Grand Pharmaceutical and Healthcare Holdings Ltd. reported audited consolidated cash flow results for the year ended December 31, 2014. For the year, the company's net cash generated from operating activities was HKD 527,300,000 compared to HKD 791,929,000 a year ago. Purchase of property, plant and equipment was HKD 428,715,000 compared to HKD 877,649,000 a year ago.

China Grand Pharmaceutical and Healthcare Holdings Ltd. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

China Grand Pharmaceutical and Healthcare Holdings Ltd. reported audited consolidated earnings results for the year ended December 31, 2014. For the period, the company's turnover was HKD 3,122,116,000 compared to HKD 2,658,282,000 a year ago. Profit before tax was HKD 202,921,000 compared to HKD 132,280,000 a year ago. Profit for the year was HKD 175,723,000 compared to HKD 105,286,000 a year ago. Profit for the year attributable to owners of the company was HKD 175,208,000 compared to HKD 99,658,000 a year ago. Diluted earnings per share was 8.86 cents compared to 5.08 cents a year ago.

China Grand Pharmaceutical and Healthcare Holdings Ltd. to Report Fiscal Year 2014 Final Results on Mar 24, 2015

China Grand Pharmaceutical and Healthcare Holdings Ltd. announced that they will report fiscal year 2014 final results on Mar 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
512:HK $2.17 HKD +0.01

512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY73.46 CNY -0.14
View Industry Companies
 

Industry Analysis

512

Industry Average

Valuation 512 Industry Range
Price/Earnings 24.9x
Price/Sales 1.4x
Price/Book 3.8x
Price/Cash Flow 24.3x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA GRAND PHARMACEUTICAL A, please visit www.chinagrandpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.